Trident Lifeline Ltd (TLL) is currently trading at 289.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Trident Lifeline Limited is a rapidly growing pharmaceutical company, specializing in manufacturing and exporting pharmaceutical formulations globally. It operates in several regions, including Africa, Latin America, and Asia. The company has shown robust financial growth, with a 44% year-over-year revenue increase in Q3FY26. Its EBITDA also surged by 53% in the same period, demonstrating a strong operational performance. Strategic acquisitions have been pivotal for Trident, acquiring stakes in subsidiaries like TNS Pharma, TLL Parenterals, and Trident Mediquip, enhancing its manufacturing and distribution capabilities. A hybrid manufacturing model is at the core of Trident's operations, combining in-house manufacturing with contract manufacturing to meet growing demands effectively. Trident Lifeline is heavily investing in product registrations, with over 3,500 products in the pipeline, which could significantly propel its market presence and revenue growth in the coming years.

Over the past 52 weeks, Trident Lifeline Ltd has traded between a low of ₹229.95 and a high of ₹328.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Trident Lifeline Ltd has a market capitalization of approximately 343.76. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Trident Lifeline Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.91 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 343.76 Cr, Trident Lifeline Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Trident Lifeline Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Trident Lifeline Ltd is 15.91. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The company appointed Ms. Smita Kiran Davda and Mr. Sachin Bhandari as Additional Directors in the capacity of Non-Executive Independent Directors with effect from June 13, 2026, subject to shareholder approval.